Glucocorticoid injections into myofascial trigger points to treat knee osteoarthritis.
Official title: Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Musculoskeletal Pain(CMP), Chronic Migraine and Cervicogenic Headache
Run by Beijing Tiantan Hospital · NCT07347028 · Data updated 2026-11-12
This study will test whether injecting corticosteroid into myofascial trigger points reduces pain and improves function for adults 45 and older with knee osteoarthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years and up |
| Sex | All |
| Enrollment | 238 (estimated) |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | January 1, 2027 |
| Registry record updated | October 8, 2026 |
| Trial ID | NCT07347028 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 45 or older with radiographic knee osteoarthritis (Kellgren-Lawrence grade 1–4), disease lasting more than 3 months, an NRS pain score ≥3 despite conservative treatment, and at least one clinically confirmed myofascial trigger point who can give informed consent.
✕Probably not a fit
Patients with corticosteroid allergy, recent intra-articular injection, long-term steroid use, significant comorbidities (severe organ dysfunction, coagulation disorders, inflammatory rheumatic disease), substance misuse, or other exclusion criteria are unlikely to benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized, blinded-outcome, non-inferiority trial comparing glucocorticoid injections at myofascial trigger points (MTrPs) with complex intra-articular (joint cavity) injections for knee osteoarthritis. Eligible patients are randomized to one of the two injection approaches and followed for two years. Pain (NRS), joint function (WOMAC), and other clinical outcomes are collected at prespecified intervals to compare long-term efficacy. The trial is single-center and conducted at Beijing Tiantan Hospital.
Why it matters
Potential benefit: If successful, patients could achieve similar or better long-term pain relief and function with a simpler, potentially less invasive MTrP injection approach.
How similar studies have gone: Smaller domestic and international studies have reported symptom relief from glucocorticoid injections at MTrPs, but long-term randomized comparisons versus intra-articular injections remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of knee osteoarthritis with radiographic evidence of osteoarthritis (Kellgren-Lawrence grade 1-4) confirmed by at least two orthopedic surgeons, pain specialists, or general practitioners, with physical examination confirming at least one myofascial trigger point; * Disease duration exceeding 3 months; * Age ≥ 45 years; * Numerical Rating Scale (NRS) score ≥ 3 points despite prior conservative pharmacological treatment; * Signed informed consent form. Exclusion Criteria: * History of allergy to trial medications such as corticosteroids; * Alcohol abuse; long-term use of opioids (exceeding 2 weeks or more than 3 days per week for over 1 month); suspected use of sedative or analgesic medications; patients on long-term steroid therapy; * Severe neurological disorders, significant hepatic or renal dysfunction, heart failure, coagulation abnormalities, gastric ulcer, diabetes, inflammatory rheumatic diseases, etc.; * Intra-articular injection within the past 6 months or planned joint replacement surgery; * Inability to use pain assessment scales; * Presence of local or systemic infection; * Pregnant or lactating patients.
Where it's running
-
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Fang Luo
- Email: 13611326978@163.com
- Phone: +86 13611326978
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Steroid injection into neck muscle trigger points versus C2 dorsal root ganglion (nerve) block for chronic cervicogenic headache
This trial will test whether steroid injections into neck myofascial trigger points work as well as C2 dorsal root ganglion (nerve) blocks to reduce pain in adults with chronic cervicogenic headache.
-
Steroid injections into myofascial trigger points versus joint injections for shoulder osteoarthritis
This study will test whether steroid injections into muscle trigger points work as well as steroid injections into the shoulder joint for adults with shoulder osteoarthritis and ongoing shoulder pain.
-
Trigger-point steroid injections versus hip joint steroid injections for hip osteoarthritis
This test compares steroid injections into myofascial trigger points versus injections into the hip joint to see which reduces pain and improves function in people aged 45 and older with hip osteoarthritis.
-
Remote electrical neuromodulation to test pain inhibition in migraine and fibromyalgia
We’re testing if the Nerivio wearable can boost the body’s natural pain-inhibition system (CPM) and reduce pain more than a sham device in adults with migraine or fibromyalgia.
-
Post Isometric Relaxation vs Reciprocal Inhibition for Cervicogenic Headache
This study tests whether two gentle neck muscle techniques, post isometric relaxation and reciprocal inhibition, help people with cervicogenic headache more than a standard physical therapy routine.
-
Kaltenborn vs Maitland Mobilization for Cervicogenic Headache
This trial tests whether Kaltenborn mobilization helps people with cervicogenic headache more than Maitland mobilization.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.